In addition, TMZ-resistant tumors that rely on OXPHOS (mitochondrial oxidative phosphorylation system) promote the infiltration and enrichment of anti-inflammatory M2-like GAMs (CD45+CD11b+CD206+), particularly at the periphery of the tumor mass. Here, MRC1 is linked to neoplasm.